By treating leadership as a future role, research training overlooks skills trainees practice daily and delays their ...

Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...

LINE-1 retrotransposons are mobile genome parasites that drive cancer evolution by reshuffling the host genome.

Simulations and patient data indicated that it’s not just which gut microbes are present, but also how they interact, that ...

Builds on success of existing partnership including development of automated library preparation methods on SPT Labtech’s ...

In this roundtable webinar, discover how scientists improve tumor-informed minimal residual disease (MRD) testing for ...

Hong Chen is a Professor of Biomedical Engineering and Neurosurgery at Washington University in St. Louis. Her research focuses on developing ultrasound technologies for the diagnosis and treatment of ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.